“Market research commissioned by the CMC estimates that the CBD market is currently one of the fastest growing wellbeing product categories in the UK. At the current rate it will be worth almost £1B per annum by 2025.”
NVC Consultants fully endorse the principles of EIS legislation, alongside advocating the growth of small and medium-sized enterprises within the UK. Therefore, we are delighted to offer investors the chance to support a business model that is set to become a global brand, promoting wellness from nature.
Medicaleaf have a vision to become Europe’s leading provider of health and wellness cannabidiol innovations. They wish to improve the quality of life for those suffering from pain and ailments. Using advanced and natural processing techniques, Medicaleaf is introducing a wellness system, in the form of complimentary products to help ensure a balanced intake of CBD. Medicaleaf plan to launch the most energetic marketing and awareness campaign in the health and wellness sector.
From a standing start, Medicaleaf intends to generate revenue in excess of £5.3 million in this first trading year, with sales increasing by 372% in year two and a further 88% in year three, as the demand-supply equation is successfully welded.
Medicaleaf will have a post-raisevaluation of £20 million with expectations to reach a pre-floatation valuation of £200 million in three years’ time.
Management has applied for Enterprise Investment Scheme (EIS) Advance Assurance with HMRC, anticipating that eligible investors may also benefit from EIS tax reliefs in the current or previous tax year.
There has never been a better time to own and invest in the CBD health and wellness sector.
For more information on this investment opportunity and to obtain the Investor Memorandumplease contact us today.